Catherine Lai, MD, MPH, is an Innovation Faculty member at PC3I and the Physician Leader of the Leukemia Clinical Research Unit at Abramson Cancer Center. Dr. Lai specializes in detecting, monitoring, and treating acute leukemia and myeloid malignancies in adults. Dr. Lai’s research focuses on integrating health outcomes into clinical trials with novel therapeutics, with a focus on measuring physiologic age and interventions to improve early mortality and overall survival, minimize treatment toxicity and maximize tolerability to therapy.

Most recently, Dr. Lai served as the Director of Leukemia at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center in Washington, DC. Dr. Lai is an Associate Professor of Hematology/Oncology at the Perelman School of Medicine at the University of Pennsylvania. She completed her Hematology/Oncology fellowship at the National Cancer Institute of the National Institutes of Health. Dr. Lai received her master’s in Public Health in Epidemiology from George Washington University.